Validation of a tool to assess occupational therapy needs for cancer survivors
Validation of the Screen of Cancer Survivorship - Occupational Therapy Services (SOCS-OTS) Tool for Use in a Physical Medicine Rehabilitation Clinic
M.D. Anderson Cancer Center · NCT06329531
This study is testing a new tool to see if it can accurately identify cancer survivors who need occupational therapy services.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 80 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | M.D. Anderson Cancer Center (other) |
| Locations | 1 site (Houston, Texas) |
| Trial ID | NCT06329531 on ClinicalTrials.gov |
What this trial studies
This study aims to validate the Screen of Cancer Survivorship - Occupational Therapy Services (SOCS-OTS) tool by comparing its results with a standardized screening measure currently used at MD Anderson Cancer Center. The primary focus is on diagnostic testing to evaluate the sensitivity and specificity of the SOCS-OTS in identifying patients who require occupational therapy services. Additionally, the study will assess the predictive accuracy of the SOCS-OTS regarding OT referrals and explore demographic factors associated with the need for OT. Test-retest reliability of the SOCS-OTS will also be established.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who are currently receiving medical follow-up in the Physical Medicine and Rehabilitation clinic.
Not a fit: Patients with cognitive impairments that hinder their ability to consent or participate will not benefit from this study.
Why it matters
Potential benefit: If successful, this tool could improve the identification of cancer survivors who need occupational therapy, leading to better patient care and outcomes.
How similar studies have performed: Other studies have shown success in validating screening tools for occupational therapy needs, making this approach promising.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Must be 18 years an older 2. Currently medically followed in the PMR clinic (with or without acute disease) 3. Must speak and read English. The AM-PAC is currently validated in adults only. Additionally, the assessment tools are in English without translation into other languages, therefore only clients who do speak and read English will be included. Pregnant participants are not excluded. Exclusion Criteria: 1\. Potential participants with confusion and cognitive impairments that might hinder their ability to sign an informed consent form or participate in the study.
Where this trial is running
Houston, Texas
- MD Anderson Cancer Center — Houston, Texas, United States (RECRUITING)
Study contacts
- Principal investigator: Ekta Gupta, MD — M.D. Anderson Cancer Center
- Study coordinator: Ekta Gupta, MD
- Email: egupta@mdanderson.org
- Phone: (713) 745-2327
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Cancer, Occupational Therapy